0001181431-12-003824.txt : 20120125 0001181431-12-003824.hdr.sgml : 20120125 20120125160859 ACCESSION NUMBER: 0001181431-12-003824 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120124 FILED AS OF DATE: 20120125 DATE AS OF CHANGE: 20120125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ehrlich Christopher B CENTRAL INDEX KEY: 0001293973 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51967 FILM NUMBER: 12544902 MAIL ADDRESS: STREET 1: C/O INTERWEST PARTNERS STREET 2: 2710 SAND HILL ROAD, 2ND FLOOR CITY: MENLO PARK STATE: CA ZIP: 94025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc CENTRAL INDEX KEY: 0001178711 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330960223 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: (510) 215-3500 MAIL ADDRESS: STREET 1: 1003 W. CUTTING BLVD STREET 2: SUITE 110 CITY: POINT RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: NOVACEA INC DATE OF NAME CHANGE: 20020724 4 1 rrd330175.xml EHRLICH GRANT X0304 4 2012-01-24 0 0001178711 Transcept Pharmaceuticals Inc TSPT 0001293973 Ehrlich Christopher B C/O TRANSCEPT PHARMACEUTICALS, INC. 1003 W. CUTTING BLVD, SUITE 110 POINT RICHMOND CA 94804 1 0 1 0 Common Stock (right to buy) 8.18 2012-01-24 4 A 0 7000 0 A 2022-01-24 Common Stock 7000 7000 D The option vests in twelve equal monthly installments beginning on February 24, 2012. /s/ Marilyn Wortzman, by power of attorney 2012-01-25